LISA BRENNER: Open Payments
NPI 1396151163 · PHOENIXVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,514 in 15 payments from 9 companies in 2025. Trend: 2023 $1,163 · 2024 $1,182 · 2025 $1,514
Food & beverage: $1,514
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $622 |
| Novo Nordisk Inc | 2 | $200 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $125 |
| Alkermes, Inc. | 1 | $122 |
| E.R. Squibb & Sons, L.L.C. | 1 | $118 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $113 |
| Mallinckrodt Hospital Products Inc. | 1 | $100 |
| Lilly USA, LLC | 1 | $99 |
| Mannkind Corporation | 1 | $15 |
Products named: CAPLYTA, LUMRYZ, LYBALVI, COBENFY, ACTHAR, ZEPBOUND, AFREZZA.
Industry payments across PA — which companies pay providers there.
